Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance.
It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine.
Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective.
*Expert reviews in clinical and basic drug resistance research in oncology and infectious disease
*Describes emerging technologies and therapies, particularly those that overcome drug resistance
*Emphasises common themes in microbial and cancer research
《Drug Resistance Updates》是一本由Churchill Livingstone出版商出版的專業醫學期刊,該刊創刊于1998年,刊期Bimonthly,該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:醫學 1區,小類學科:藥學 1區;在JCR(Journal Citation Reports)分區等級為Q1。該刊發文范圍涵蓋藥學等領域,旨在及時、準確、全面地報道國內外藥學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為22.841,平均審稿速度約稿?周期不定。
大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
醫學 | 1區 | PHARMACOLOGY & PHARMACY 藥學 | 1區 | 是 | 是 |
JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
Q1 | PHARMACOLOGY & PHARMACY | Q1 | 22.841 |
影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
22.841 | 100 | 24.62% | 0.00% | 未開放 | 約稿?周期不定 |